{"id":"NCT00879333","sponsor":"Novartis Pharmaceuticals","briefTitle":"Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)","officialTitle":"A Randomized, Double-blind, Multi-center Phase III Study Comparing Everolimus (RAD001) Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Gastric Cancer After Progression on 1 or 2 Prior Systemic Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-07","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2009-04-10","resultsPosted":"2015-04-06","lastUpdate":"2015-11-03"},"enrollment":656,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Advanced Gastric Cancer"],"interventions":[{"type":"DRUG","name":"Everolimus","otherNames":["RAD001"]},{"type":"DRUG","name":"Everolimus placebo","otherNames":[]},{"type":"DRUG","name":"Best Supportive Care (BSC)","otherNames":[]}],"arms":[{"label":"Everolimus + BSC","type":"EXPERIMENTAL"},{"label":"Placebo + BSC","type":"PLACEBO_COMPARATOR"}],"summary":"This study is designed to assess the safety and efficacy of RAD001 monotherapy in patients with advanced gastric cancer which has progressed after one or two lines of prior chemotherapy.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"2.5 years","effectByArm":[{"arm":"Everolimus 10mg/Daily","deltaMin":5.39,"sd":null},{"arm":"Placebo","deltaMin":4.34,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":122,"countries":["United States","Argentina","Australia","Belgium","Canada","China","France","Germany","Hong Kong","Israel","Italy","Japan","Mexico","Netherlands","New Zealand","Peru","Russia","South Korea","Spain","Taiwan","Thailand","United Kingdom"]},"refs":{"pmids":["24043745"],"seeAlso":["http://www.novartisclinicaltrials.com/etrials/searchTrial.do?trialID=717"]},"adverseEventsSummary":{"seriousAny":{"events":210,"n":437},"commonTop":["Decreased appetite","Fatigue","Stomatitis","Nausea","Vomiting"]}}